Moody National Bank Trust Division’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
AA
MAM
DO
QCM
EAM
CGH
CUAMC
Moody National Bank Trust Division's LKFT Position: Q2 2026 in Review
Moody National Bank Trust Division sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 20,849 shares — an estimated $625K sold.
Moody National Bank Trust Division first reported a position in LKFT in Q3 2018 and held it in 25 quarters. The position peaked at $915K in Q4 2023. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Moody National Bank Trust Division reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
- Moody National Bank Trust Division sold 20,849 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $625K.
- Moody National Bank Trust Division first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 25 quarters.
- Moody National Bank Trust Division's Lakefront Biotherapeutics American Depositary Shares position peaked at $915K in Q4 2023.
- 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.